Home/ Applications/ Organoid Culture/ Organoid Live Imaging

zenCELL owl · 24-Channel · In-Incubator · SeamlessBio DACH

Organoid Live Cell Imaging — Continuous Brightfield Monitoring Without Sample Removal

zenCELL owl places up to 24 simultaneous brightfield imaging channels directly inside the incubator — monitoring organoid growth, morphology, and drug response continuously from seeding to endpoint without ever removing samples. No phototoxicity. No thermal shock. No CO₂ disruption. The only in-incubator imager available with exclusive OrganoMedium™ bundle in DACH.

Request Demo zenCELL owl Website →

Why conventional end-point imaging fails for organoids: Organoids are living, dynamic 3D structures — they grow, differentiate, respond to drugs, and sometimes die unexpectedly. All of this happens between sampling points. Removing organoids from the incubator even briefly causes temperature shock (>5°C), CO₂ equilibration disruption, and mechanical stress that alter growth trajectories. Fluorescence imaging causes phototoxicity over extended time courses. zenCELL owl eliminates all of these problems: continuous brightfield imaging inside the incubator, across 24 channels simultaneously, with no sample removal.

24 Channels

Monitor 24 cultures simultaneously

24 independent brightfield imaging channels in one instrument. Run dose-response comparisons, treatment groups, and controls in parallel — without multiple instruments.

In-Incubator

Never remove samples

zenCELL owl operates at full incubator conditions — 37°C, 5% CO₂, humidity. Organoids are never disturbed. No thermal shock, no CO₂ disruption, no phototoxic stress.

Brightfield

No labels, no photobleaching

High-contrast brightfield phase-like imaging captures organoid morphology, size, structure, and response without fluorescent dyes. Cost-effective and compatible with all live cells.

HTS Ready

96- and 384-well compatible

Compatible with Hamilton, Tecan, and Beckman automation platforms. True high-throughput organoid screening without confocal infrastructure or manual endpoint assays.

What zenCELL owl reveals that endpoint assays miss

When organoid researchers use only endpoint assays — viability, ATP, LDH — they see the result but miss the process. zenCELL owl captures the complete temporal dynamics:

Drug response timing: When did the organoid start responding? Is the response reversible if the drug is washed out? Is there a dose-dependent delay in onset? These questions are answerable with time-resolved brightfield imaging — impossible with endpoint data alone.

Morphological transitions: Does the drug cause organoid collapse, swelling, fragmentation, or loss of internal structure? Endpoint viability assays report cell death but not the mode or timing. Brightfield timelapse captures the complete sequence.

Failed cultures identified early: In iPSC-derived organoid protocols running over weeks, zenCELL owl identifies failed differentiation events at day 5–7 — not at the endpoint when 4 weeks of culture have been wasted. Early intervention or re-seeding becomes possible.

Cardiac organoid contractility: In well-developed cardiomyocyte aggregates, rhythmic contraction is visible in brightfield timelapse — a non-invasive functional quality indicator without calcium dye phototoxicity.

Growth curve generation: Automated size measurement across all 24 channels generates growth curves from day 1 to endpoint — identifying outlier wells, batch effects, and seeding density problems automatically.

zenCELL owl for organoids — key specs

24 independent imaging channels, simultaneous
In-incubator operation — 37°C, 5% CO₂, humidity
Brightfield — no fluorescence required
96-well and 384-well plate compatible
Automation compatible (Hamilton, Tecan, Beckman)
Time-lapse from minutes to weeks
Automated size and morphology analysis
Scratch assay / migration analysis
No phototoxicity risk
No sample removal — no thermal or CO₂ disruption
Bundle available with OrganoMedium™
DACH distribution via SeamlessBio and innoME

zenCELL owl Applications by Organoid Type

Organoid Type	zenCELL owl Application	What Is Captured	Why Brightfield Is Sufficient
Tumour spheroids	Drug cytotoxicity kinetics, IC₅₀ time-course, growth inhibition	Size over time, morphology change, edge definition, internal density	Spheroid collapse, fragmentation, and growth arrest are clearly visible in brightfield
Intestinal organoids	Crypt-villus structure monitoring, drug-induced damage, inflammation response	Budding morphology, crypt formation, structural integrity	Crypt structure and bud formation are high-contrast brightfield features
Liver organoids / hepatospheres	DILI (drug-induced liver injury) time course, hepatotoxicity	Spheroid compaction, internal structure, size change, fragmentation	Hepatocyte aggregate structure is clearly distinguishable from necrotic tissue
Brain / cerebral organoids	Growth over weeks, ventricular zone formation, differentiation monitoring	Overall size, surface morphology, internal dark/light regions	Cerebral organoid growth zones are distinguishable by optical density in brightfield
Cardiac organoids / aggregates	Contractility monitoring (brightfield timelapse), drug cardiotoxicity	Rhythmic contraction visible in timelapse — quality indicator	Cardiomyocyte contraction produces measurable pixel displacement in brightfield
Patient-derived organoids (PDOs)	Drug sensitivity screening, personalised oncology	Growth kinetics per treatment condition, morphological response	Growth rate differences between drug conditions quantified automatically
iPSC-derived organoids	Differentiation quality monitoring weeks 1–8	Structural development, failed culture identification at day 5–7	Failed differentiations produce characteristic unstructured brightfield appearance

zenCELL owl vs Conventional Organoid Imaging Approaches

Approach	zenCELL owl	Manual Endpoint Imaging	Benchtop Confocal	Plate Reader (ATP/LDH)
In-incubator operation	✓ Always	✗ Sample removal	✗ Sample removal	✗ Sample removal
Continuous time-lapse	✓ Day 1 to endpoint	✗ Snapshots only	⚠ Manual, not continuous	✗ Not imaging
No sample disruption	✓	✗ Thermal shock, CO₂	✗ Thermal shock, CO₂	✗
No fluorescent labels needed	✓ Brightfield	⚠ Often required	✗ Fluorescence required	✗ Biochemical only
Phototoxicity risk	✓ None (brightfield)	✗ Yes (fluorescence)	✗ High (confocal)	✓ None
24 wells simultaneously	✓	✗ One at a time	✗ Sequential	✓
HTS 96/384-well compatible	✓	✗	⚠ Time-consuming	✓
Morphological information	✓ Full structural	✓	✓ Best resolution	✗ None
OrganoMedium™ bundle	✓ Exclusive DACH	✗	✗	✗

Frequently Asked Questions

Does zenCELL owl support fluorescence imaging for organoids?

zenCELL owl is primarily a brightfield imaging system. For most organoid applications — growth monitoring, drug response, morphology, iPSC differentiation quality — brightfield provides sufficient information without fluorescent labelling. Fluorescence options exist for specific applications where fluorescent reporters or dyes are used. The key advantage of brightfield-first imaging is zero phototoxicity risk over extended time courses (days to weeks), which is critical for long-term organoid culture experiments where fluorescence illumination would cause cumulative damage.

How many wells can zenCELL owl monitor simultaneously?

zenCELL owl provides 24 independent imaging channels simultaneously. For 96-well plates, this means running 24 wells continuously in parallel — typical for dose-response experiments with 4–6 dose levels and 3–4 replicates per condition. For 384-well format HTS applications, multiple wells can be monitored per channel depending on configuration. Contact us for detailed configuration options for your specific throughput requirements.

What is the advantage of brightfield over fluorescence for organoid drug screening?

For organoid drug screening over 48–168 hours, fluorescence illumination accumulates photodamage that can artifactually affect cell viability — creating a confound between drug-induced and light-induced cell death. Brightfield imaging causes no phototoxic stress, allowing continuous monitoring over the complete drug exposure period without affecting the biological readout. Additionally, brightfield does not require dye preparation, has no photobleaching, and is applicable to all organoid types without labelling optimisation.

Is zenCELL owl compatible with the CERO 3D bioreactor for long-term organoid culture?

zenCELL owl is designed for standard multi-well plate formats (6, 12, 24, 48, 96, 384-well). For organoids grown in CERO 3D tubes, periodic transfer to well plates for zenCELL owl imaging is the standard workflow — cells are moved briefly to the imaging plate and returned to the CERO 3D for continued culture. For workflows requiring fully non-invasive CERO 3D monitoring, we recommend combining CERO 3D for scaffold-free long-term expansion with zenCELL owl for endpoint and intermediate morphology assessment at defined culture day points.

Can zenCELL owl quantify organoid size and growth rate automatically?

Yes — zenCELL owl includes automated image analysis software that measures organoid/spheroid projected area and diameter over time, generating growth curves automatically across all 24 channels. The software detects organoid boundaries in brightfield images, tracks size changes over time, and exports numerical data for statistical analysis. For drug screening applications, this enables IC₅₀ calculation from time-resolved growth data rather than single endpoint viability — a more informative and reproducible readout.

← All Application Guides Overview

zenCELL owl Demo + OrganoMedium™ Bundle

Request a zenCELL owl demo with your own organoid samples. Exclusive DACH starter bundle: zenCELL owl + 3 months OrganoMedium™ supply. Free OrganoMedium™ samples for protocol setup.
Email: info@seamlessbio.de | +49 851 37932226 | zencellowl.com

Request Demo Organoid Guide →

Application Organoid live imaging